Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EQ Health Acquisition Corp was a special purpose acquisition company formed to pursue a business combination in the healthcare sector, particularly healthcare services. It did not operate a therapeutic, pharmaceutical, biotech, medical device, or clinical development business of its own. Instead, its purpose was to raise capital in the public markets and merge with or acquire a target company. Available public information indicates that the SPAC did not complete an initial business combination and was subsequently liquidated in December 2022. As a result, it has no product pipeline, drug programs, or proprietary healthcare platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EQ Health Acquisition Corp.